title: [Clinical value in detection of blood miRNAs in patients with colorectal cancer].
abstract: Colorectal cancer (CRC) is the most common cancer in digestive system, with the highest mortality rate. Its pathogenesis, diagnosis and treatment have been studied extensively. With the deepening of the investigations, more and more studies show that miRNA is closely related with the carcinogenesis, diagnosis and treatment of CRC. The abnormal expression of blood miRNA is expected to become the biomarkers for early diagnosis of CRC and prognostic evaluation, and it may provide a new strategy for clinical treatment.
authors.affiliation: Department of Hepatopancreatobiliary Surgery, Second Clinic Medicine College, Jinan University, Shenzhen People's Hospital, Shenzhen Guangdong 518020, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Tan
authors.affiliation: Translational Medicine Research Center, Second Clinic Medicine College, Jinan University, Shenzhen People's Hospital, Shenzhen Guangdong 518020, China.
authors.forename: Furong
authors.initials: F
authors.lastname: Li
authors.affiliation: Department of Hepatopancreatobiliary Surgery, Second Clinic Medicine College, Jinan University, Shenzhen People's Hospital, Shenzhen Guangdong 518020, China.
authors.forename: Xiaofang
authors.initials: X
authors.lastname: Yu
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D063646:Carcinogenesis; D015179:Colorectal Neoplasms / Q000097:blood*; D055088:Early Detection of Cancer; D006801:Humans; D035683:MicroRNAs / Q000097:blood*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D035683:MicroRNAs